Arnatar Therapeutics

San Diego, California, United States · Biotechnology, Health Care · 35 employees

Arnatar Therapeutics is a biotechnology company based in San Diego, CA, focusing on advancing RNA-based therapies for severe and underserved diseases. The company utilizes its proprietary ACT-UP1 platform to develop innovative treatments, including its lead candidate ART4 for Alagille Syndrome. Founded in 2022, Arnatar aims to deliver medicines for various diseases through a combination of siRNA a

See plans & pricing → Track Arnatar Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.